Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: SW-682 in Advanced Solid Tumors [Phase 1]
Phase 1 trial update indicates SW-682 for advanced solid tumors, including malignant mesothelioma, is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Group Meaning-Centered Psychotherapy for the Improvement of Wellbeing in Caregivers of Patients With Serious Illness [NA]
A Mayo Clinic clinical trial is investigating group meaning-centered psychotherapy to improve wellbeing in caregivers of patients with serio…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
Mayo Clinic is recruiting for the Radiotherapy Patient Outcomes Registry and Biobanking Study, a registry collecting radiotherapy patient ou…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors [EARLY_Phase 1]
A phase 1 clinical trial assessing the efficacy and safety of CAR-DC in patients with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Avelumab Program Rollover Study [Phase 3]
This document provides a clinical trial update for the avelumab program rollover study (Phase 3). The trial is currently active but not recr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours [Phase 1, Phase 2]
Ipsen is conducting a Phase 1/2 trial of IPN01194 as a single-agent therapy for adults with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors [Phase 1]
A Phase 1 study evaluating AB521 as both a single agent and in combination regimens for clear cell renal cell carcinoma and other solid tumo…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial [NA]
Clinical trial update indicating that the AVATARS trial is currently recruiting adolescent and young adult cancer survivors to evaluate virt…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: COAST Therapy in Advanced Solid Tumors and Prostate Cancer [Phase 1, Phase 2]
Clinical trial update on COAST Therapy for advanced solid tumors and recurrent prostate cancer, currently recruiting for Phase 1 and Phase 2…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers [Phase 1]
Phase 1 trial update for IOA-244, a PI3Kδ inhibitor, being studied in metastatic cancers with status currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 study evaluating CGT6297, a mutant-selective inhibitor, in adults with advanced solid tumors, including PIK3CA-mutant endo…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
This clinical trial update notes a Phase 1 study of BAL0891 by SillaJen in patients with advanced solid tumors, including triple-negative br…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor [Phase 1, Phase 2]
Phase 1/2 trial update for HMPL-A580 in adults with advanced or metastatic solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) [Phase 2]
The CAPTUR Phase 2 trial by the Canadian Cancer Trials Group is currently recruiting and evaluates profiling and targeted agent utilization …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
This clinical trial update describes an ongoing prospective evaluation of delayed effects after pediatric CAR T cell therapy in acute lympho…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options [Phase 1, Phase 2]
Ongoing pediatric study of entrectinib (Rxdx-101) for locally advanced or metastatic solid tumors and/or primary CNS tumors with no satisfac…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors [Phase 1]
A Phase 1 clinical trial to evaluate VG2062 in patients with solid tumors is currently recruiting, assessing safety, tolerability, pharmacok…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) [Phase 2]
A Phase 2 trial evaluating BMS-986504 as monotherapy and in combination for MTAP-deleted advanced or metastatic solid tumors; the study is n…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is an update on an ongoing Phase 1/2a first-in-human study of BMS-986517 in adults with advanced solid tumors; the trial is currently r…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors [Phase 1]
This clinical trial update announces the first-in-human Phase 1 study of GSK4381562 in participants with advanced solid tumors; the trial st…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a first-in-human study of IMP1734, a PARP1 selective inhibitor, in participants with advanced solid tum…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Clinical trial update for a Phase 1-2 study of ASTX660 in subjects with advanced solid tumors and lymphomas; recruitment status is ACTIVE_NO…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial update for DS-1055a in relapsed or refractory locally advanced or metastatic solid tumors; the study is currently a…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies [Phase 4]
Phase 4 trial evaluating olutasidenib for drug-drug interaction in IDH1-mutant malignancies. The study is currently recruiting in AML, gliom…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor [Phase 1]
Phase 1 study to assess the safety, tolerability, and pharmacokinetics of ABSK-021 in patients with advanced solid tumors. The study include…